Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Rifampicin Levels Shape Tuberculosis Treatment Success
October 2025
Higher rifampicin exposure accelerated bacillary clearance and predicted pulmonary tuberculosis treatment outcomes in patients.
Read more
27 Oct 2025
Rifampicin Levels Shape Tuberculosis Treatment Success
Higher rifampicin exposure accelerated bacillary clearance and predicted pulmonary tuberculosis treatment outcomes in patients.
25 Oct 2025
Pediatric Hepatitis C Fully Treated with Sofosbuvir
A recent study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17 years.
23 Oct 2025
IDWeek 2025: RSV Shot After Birth Sparks Powerful Immunity
RSV immunization in infants is safe and produces high antibody levels, regardless of whether mothers received vaccination during pregnancy.
22 Oct 2025
IDWeek 2025: HIV Prevention Breakthrough Could Cost $25 Annually
A new study presented at IDWeek 2025 suggests that HIV preventive treatment with lenacapavir could be produced for as little as $25 per patient per year.
22 Oct 2025
RSV Vaccine Cuts Severe Illness in Seniors
RSV vaccine effectiveness in older adults reached high levels against acute respiratory illness in 2023–2024 postlicensure testing.
21 Oct 2025
IDWeek 2025: Zoster Vaccine Linked to Lower Cardiovascular, Dementia Risk
Prior zoster vaccination reduces risks of cardiovascular events, dementia, and death after shingles infection, new IDWeek 2025 data show.
20 Oct 2025
IDWeek 2025: C. diff Deaths Show Stark Demographic Gaps
A 25-year USA study finds C. diff deaths highest among White people, women, and city residents, though overall mortality has fallen since 2015.
18 Oct 2025
Rural US Experience with Invasive Aeromonas Infections
Invasive Aeromonas infections were uncommon yet severe in a four-year rural U.S. review of cases.
Loading posts...
1
2
3
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View